3 hours Atossa Therapeutics (NASDAQ:ATOS) Upgraded to “Hold” at StockNews.comMarketBeat
StockNews.com upgraded shares of Atossa Therapeutics from a “sell” rating to a “hold” rating in a research note on Friday.
XStockNews.com upgraded shares of Atossa Therapeutics from a “sell” rating to a “hold” rating in a research note on Friday.
X